The Redefining Early Stage Investments (RESI) conference series is an established global circuit partnering conference for early stage life science companies to source investors, create relationships, and close the gap on finding capital. These events give life science companies the chance to start, resume or close conversations with relevant investors, creating a global dialogue to bring products to market at a faster pace. RESI brings qualified investors from ten categories including, Family Offices, Venture Philanthropy, Patient Groups, Corporate Development, Virtual Pharma, Endowments, Foundation, and Angels.
10% discount on registration for United Life Sciences members.
For more information and to register click here.